We invite you to engage in an interactive roundtable with leading neurologists, researchers, and patients to help advance the discovery and implementation of ALS digital biomarkers in clinical trials through our collaborative efforts.

 

Joining our participatory roundtable, you will be the first to learn about our latest study results on ALS digital biomarkers as well as have the opportunity to hear why major pharmaceutical companies have joined the consortium to partner in our research, which will be expanded to include analyzing data from wearables and smartphones.

 

You will also hear about the survey results submitted by the patients and caregivers for the NIH ALS research priorities RFI as well as the scientific analysis of the survey with NLP (Natural Language Processing) from our IBM Research collaborator.

 

As always, we approach each roundtable to encourage out-of-the-box thinking, and to kick it off, we’ve asked our partner from the C-Path institute to speak about the results of the Parkinson’s 3DT Digital Biomarker Initiative.

 

We look forward to hearing your ideas and sharing our knowledge.